These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 15017933)

  • 1. High blood sugar, homocysteine boost artery-reclogging risks.
    Health News; 2004 Mar; 10(3):6. PubMed ID: 15017933
    [No Abstract]   [Full Text] [Related]  

  • 2. Type 2 diabetes mellitus and colorectal cancer risk: is homocysteine the missing link?
    Phelip JM; Roblin X
    Am J Gastroenterol; 2007 Feb; 102(2):466-7. PubMed ID: 17311671
    [No Abstract]   [Full Text] [Related]  

  • 3. Homocysteine concentrations in type 2 diabetic patients with silent myocardial ischemia: a predictive marker.
    Tarkun I; Cetinarslan B; Cantürk Z; Tarkun P; Agaçdiken A; Komsuoglu B
    J Diabetes Complications; 2004; 18(3):165-8. PubMed ID: 15145328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease.
    Ndrepepa G; Kastrati A; Braun S; Koch W; Kölling K; Mehilli J; Schömig A
    Clin Chim Acta; 2006 Nov; 373(1-2):70-6. PubMed ID: 16814762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
    de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
    J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes.
    Gallagher A; Home PD
    Diabetes Res Clin Pract; 2005 Mar; 67(3):196-203. PubMed ID: 15713351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Homocysteinaemia and degenerative complications in non insulin dependent diabetes mellitus].
    Zied A; Oudi M; Chahib M; Olfa E; Brahim N; Hédi M; Habib H; Borni Z; Salem M
    Tunis Med; 2005 Sep; 83(9):537-40. PubMed ID: 16383199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and coronary angioplasty.
    J Invasive Cardiol; 2003 Sep; 15(9):suppl 3-7. PubMed ID: 14603909
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arterial wave velocity and coronary risk factors in patients with type-2 diabetes].
    Waluś-Miarka M; Czarnecka D; Kawecka-Jaszcz K; Małek A; Sztefko K; Idzior-Waluś B; Miarka P; Sieradzki J
    Przegl Lek; 2005; 62(1):46-8. PubMed ID: 16053221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between plasma homocysteine and chronic complications in type 2 diabetes mellitus].
    Li WP; Li W; Yang T
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):349-50. PubMed ID: 15772011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [When blood sugar begins to be derailed. Thus will be accounted for].
    Zimmermann GW
    MMW Fortschr Med; 2005 Aug; 147(31-32):47-8. PubMed ID: 16128201
    [No Abstract]   [Full Text] [Related]  

  • 12. The potential role of homocysteine in percutaneous coronary interventions (PCI): review of current evidence and plausibility of action.
    Stanger O
    Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):953-88. PubMed ID: 15704259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhomocysteinemia and the risk of restenosis after coronary artery stenting: fact or fiction?
    Tabrizchi R
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):935-9. PubMed ID: 15500438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart lines. Taking aim at high homocysteine.
    Harv Heart Lett; 2002 Mar; 12(7):6-7. PubMed ID: 11916634
    [No Abstract]   [Full Text] [Related]  

  • 15. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
    Boyden TF; Nallamothu BK; Moscucci M; Chan PS; Grossman PM; Tsai TT; Chetcuti SJ; Bates ER; Gurm HS
    Am J Cardiol; 2007 May; 99(10):1399-402. PubMed ID: 17493468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance as a predictor for restenosis after coronary stenting.
    Nishio K; Fukui T; Tsunoda F; Kawamura K; Itoh S; Konno N; Ozawa K; Katagiri T
    Int J Cardiol; 2005 Aug; 103(2):128-34. PubMed ID: 16080969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine enhances LDL fatty acid peroxidation, promoting microalbuminuria in type 2 diabetes.
    Kassab A; Ajmi T; Issaoui M; Chaeib L; Miled A; Hammami M
    Ann Clin Biochem; 2008 Sep; 45(Pt 5):476-80. PubMed ID: 18753419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine levels are not associated with cardiovascular autonomic function in elderly Caucasian subjects without or with type 2 diabetes mellitus: the Hoorn Study.
    Spoelstra-De Man AM; Smulders YM; Dekker JM; Heine RJ; Bouter LM; Nijpels G; Stehouwer CD
    J Intern Med; 2005 Dec; 258(6):536-43. PubMed ID: 16313477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [World news in age-related diabetes: blood sugar lowering can improve prognosis].
    Einecke D
    MMW Fortschr Med; 2005 Sep; 147(38):1. PubMed ID: 16218218
    [No Abstract]   [Full Text] [Related]  

  • 20. [Oxidant stress and cardiovascular absolute risk in Tunisian type 2 diabetes].
    Kassab A; Leban N; Ferchichi S; Feki M; Ben Limem H; Chaeib L; Miled A
    Ann Biol Clin (Paris); 2008; 66(2):151-6. PubMed ID: 18390425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.